The color of the human eye: A review of morphologic correlates and of some conditions that affect iridial pigmentation

被引:104
作者
Imesch, PD [1 ]
Wallow, IHL [1 ]
Albert, DM [1 ]
机构
[1] UNIV WISCONSIN,CTR CLIN SCI,SCH MED,DEPT OPHTHALMOL & VISUAL SCI,MADISON,WI 53792
关键词
iris color; latanoprost; melanin; pigment;
D O I
10.1016/S0039-6257(97)80018-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Iris color can be affected by a variety of ocular disorders. It is suspected that iris color may not remain constant throughout life. These observations have drawn attention to the morphologic correlates of iris color and its regulation. Differences in the iris color of normal eyes are the result of variable amounts of melanin pigment granules within a constant number of melanocytes in the superficial stroma of the iris. These melanocytes seem to reach their genetically determined amount of melanin in early childhood, and their melanin content usually remains constant in adulthood. Diseases such as Horner's syndrome and Fuchs' heterochromic iridocyclitis affect iris color, resulting in a decrease of iris pigmentation. Evidence suggests that melanin content of some melanocytes is subject to adrenergic regulation even past childhood. Application of the prostaglandin analogue latanoprost, on the other hand, leads to an increase in iris pigmentation in some patients. Studies with cultured dermal and uveal melanocytes, as well as with weal melanoma cells, however, show no increase in cell proliferation when treated with latanoprost in vitro. The mechanisms by which latanoprost affects regulation of iris pigmentation requires further investigation.
引用
收藏
页码:S117 / S123
页数:7
相关论文
共 45 条
  • [1] ALBERT DM, 1984, INVEST OPHTH VIS SCI, V25, P1284
  • [2] Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States
    Alm, A
    Camras, CB
    Watson, PG
    [J]. SURVEY OF OPHTHALMOLOGY, 1997, 41 : S105 - S110
  • [3] Calhoun FP, 1919, AM J OPHTHALMOL, V2, P255
  • [4] CAMRAS C, 1995, GLAUCOMA UPDATE
  • [5] Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma - A six-month, masked, multicenter trial in the United States
    Camras, CB
    Cioffi, GA
    VanBuskirk, EM
    Fraser, J
    Stewart, WC
    Stewart, JA
    Lustgarten, J
    Schumer, RA
    Podos, SM
    Arroyo, M
    Nitzberg, S
    Ritch, R
    Abundo, G
    Caronia, R
    Liebmann, J
    Steinberger, D
    Krupin, T
    Rosenberg, LF
    Ruderman, JM
    Clarkson, K
    Weinreb, RN
    Ochabsi, R
    Sherwood, M
    Smith, MF
    Stokes, DW
    Zam, ZS
    Wilensky, J
    Hillman, D
    Kaplan, B
    Gates, V
    Nail, C
    Zimmerman, T
    Fechtner, R
    Fenton, R
    Fenton, J
    Higginbotham, EJ
    Johnson, AT
    PollackRundle, CJ
    Weiss, E
    Yablonski, ME
    Tannenbaum, MH
    Ibrahim, F
    Ohia, E
    Neely, D
    Minckler, D
    Heuer, D
    Lee, P
    Padea, M
    Kaufman, PL
    Heatley, GA
    [J]. OPHTHALMOLOGY, 1996, 103 (01) : 138 - 147
  • [6] CARINO OB, 1994, INVEST OPHTH VIS SCI, V35, P1530
  • [7] Heredity of eye color in man
    Davenport, GC
    Davenport, CB
    [J]. SCIENCE, 1907, 26 : 589 - 592
  • [8] FINE-STRUCTURE OF MELANOCYTES IN HUMAN IRIS
    DIETERICH, CE
    [J]. ALBRECHT VON GRAEFES ARCHIV FUR KLINISCHE UND EXPERIMENTELLE OPHTHALMOLOGIE, 1972, 183 (04): : 317 - +
  • [9] DRYJA TP, 1996, ARCH OPHTHALMOL, V98
  • [10] DUKEELDER S, 1961, ANATOMY VISUAL SYSTE, V2, P167